Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
5,378,939
-
Share change
-
+5,378,939
-
Total reported value
-
$106,232,525
-
Price per share
-
$19.75
-
Number of holders
-
41
-
Value change
-
+$106,232,525
-
Number of buys
-
41
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2016
As of 30 Jun 2016,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,378,939 shares.
The largest 10 holders included
Novo A/S, FMR LLC, JPMORGAN CHASE & CO, EMERALD MUTUAL FUND ADVISERS TRUST, EMERALD ADVISERS INC/PA, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, BlackRock Fund Advisors, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and BlackRock Institutional Trust Company, N.A..
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.